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Summary
Cockayne syndrome is a multisystem sun-sensitive ge-
netic disorder associated with a specific defect in the
ability to perform transcription-coupled repair of active
genes after UV irradiation. Two complementation
groups (CS-A and CS-B) have been identified, and 80%
of patients have been assigned to the CS-B complemen-
tation group.We have analyzed the sites of themutations
in theCSB gene in 16 patients, to determine the spectrum
of mutations in this gene and to see whether the nature
of the mutation correlates with the type and severity of
the clinical symptoms. In nine of the patients, the mu-
tations resulted in truncated products in both alleles,
whereas, in the other seven, at least one allele contained
a single amino acid change. The latter mutations were
confined to the C-terminal two-thirds of the protein and
were shown to be inactivating by their failure to restore
UV-irradiation resistance to hamster UV61 cells, which
are known to be defective in the CSB gene. Neither the
site nor the nature of the mutation correlated with the
severity of the clinical features. Severe truncations were
found in different patients with either classical or early-
onset forms of the disease.
Introduction
The process of nucleotide excision repair (NER) protects
cells from damage produced in cellular DNA by a wide
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variety of carcinogens, including UV light. Three genetic
disorders—xeroderma pigmentosum (XP), Cockayne
syndrome (CS), and trichothiodystrophy (TTD)—are as-
sociated with defects in NER (Lehmann 1995). Most
patients with XP are deficient in NER and contain mu-
tations in one of seven genes (XPA–XPG) whose prod-
ucts are directly involved in NER. The recent discovery
that the products of the XPB and XPD genes are com-
ponents of the basal transcription factor TFIIH—which
has a dual role, in transcription and as a component of
NER—revealed an unexpected link between DNA repair
and transcription (reviewed in Lehmann 1995; Hoeij-
makers et al. 1996).
The clinical features of XP—namely, multiple skin ab-
normalities, including a greatly elevated skin-cancer in-
cidence caused by exposure to sunlight—are consistent
with predictions based on the hypersensitivity and hy-
permutability of cultured XP cells to UV light. In con-
trast, CS patients do not have an increased frequency of
skin cancers. CS is a multisystem disorder characterized
by severe physical and mental retardation,microcephaly,
progressive neurological and retinal degeneration, skel-
etal abnormalities, gait defects, and sun sensitivity but
no increased frequency of cancer (Nance and Berry
1992). Like XP, CS cells are hypersensitive to the lethal
effects of UV light, but NER of the bulk of genomic
DNA is unaffected. CS cells are, however, defective in a
subpathway of NER, known as “transcription-coupled
repair” (TCR), whereby damage in the transcribed
strand of active genes is rapidly and preferentially re-
paired. In CS cells, damage in active genes is repaired
at the same relatively slow rate as the bulk DNA (van
Hoffen et al. 1993). This correlates with earlier findings
that RNA synthesis recovers rapidly after UV irradiation
of normal cells, whereas this recovery does not occur in
CS cells (Mayne and Lehmann 1982). Cell-fusion studies
have assigned some 30 CS patients to two complemen-
tation groups, CS-A and CS-B (Tanaka et al. 1981; Leh-
mann 1982; Stefanini et al. 1996); 80% of them are in
the CS-B group. In addition, there are a few rare cases
of individuals with the clinical and cellular features of
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Table 1
Primers Used for Reverse Transcription and PCR
Primer Sequence Positiona Annealing Temperature
1F 5′-TCTCTGTTTCCTTGTGGGCGCTCG-3′ 31–54
1R 5′-CTCTGGCCTCATGTCTGACTCCCA-3′ 1142–1165 65C
2F 5′-CATGCTTAATGAAGCATCAGGCTTC-3′ 868–892
2R 5′-TTGAACCACGAGTCCTGATCTTGC-3′ 1734–1757 63C
3F 5′-GGTGTTAGGTGGCTGTGGGAATT-3′ 1619–1641
3R 5′-GGTATCTCGTAAGACACATGCACAC-3′ 2266–2290 67C
4F 5′-CCTCATCGGATCATTCTGTCTGGC-3′ 2081–2104
4R 5′-CATCATGGTCTGCTCCAAAGGCTGGTT-3′ 3201–3227 67C
5F 5′-ATTACGAGATACAATGAGGACACATCC-3′ 2771–2805
5R 5′-TAGCCAAGAGTGAGGAGGAAGCGA-3′ 4237–4253 67C
6F 5′-GTGAAAACAAGAGTGAGGCCAAGG-3′ 3786–3809
6R 5′-CCTTCCTTAAAGTTTTAATTCTGAGG-3′ 4688–4714 60C
a The ORF starts at nucleotide 79 and ends at nucleotide 4558 (Troelstra et al. 1992).
both CS and XP. The defects in these individuals have
been assigned to the XP-B, XP-D, and XP-G groups
(Hoeijmakers 1993).
The genes defective in the CS-A (Henning et al. 1995)
and CS-B (Troelstra et al. 1992) complementation
groups have both been cloned recently. A gene desig-
nated “ERCC6” was cloned by its ability to correct the
UV sensitivity of a mutant hamster cell line, UV61
(Troelstra et al. 1990). When the ERCC6 cDNA was
introduced into different human cell lines, it was able
to correct the UV sensitivity and post–UV-irradiation
RNA-synthesis defect in a CS-B cell line, CS1AN (Troel-
stra et al. 1992), and this cell strain was found to contain
mutations in the ERCC6 gene. ERCC6 was therefore
subsequently renamed “CSB” (Lehmann et al. 1994).
CSB encodes a 1,493-amino-acid protein, which con-
tains seven domains characteristic of DNA helicases
(Troelstra et al. 1992). However, the CSB protein is a
member of the SWI2/SNF2 family of ATPases, and, like
other members of this family, CSB does not appear to
be a helicase (Selby and Sancar 1997). The function of
the SWI/SNF protein family is thought to involve re-
modeling of protein-DNA interactions—such as chro-
matin structure—in different circumstances (Peterson
and Tamkun 1995; Cairns et al. 1996; Pazin and Ka-
donaga 1997). The CSA gene has been cloned directly
by its ability to correct the UV sensitivity of a CS-A cell
line, CS3BE, and encodes a “WD-repeat” protein (Hen-
ning et al. 1995). In order to gain more insight into
genotype-phenotype relationships in CS, we have iden-
tified mutations in the CSB gene in 16 CS patients whom
we previously had assigned to this complementation
group.
Material and Methods
Cell Culture
All CS cells were primary fibroblast cultures derived
from patients with CS. Cultures were grown in Eagle’s
minimal essential medium supplemented with 15% FCS.
The UV-sensitive Chinese hamster cell line UV61 was
grown in Eagle’s minimal essential medium with 10%
FCS.
cDNA Synthesis and PCR
RNA was extracted from ∼107 cells, by use of lysis
either (a) in NP40, by spinning out the nuclei and phenol
extraction of the cytoplasmic fraction, followed by eth-
anol precipitation, or (b) with guanidinium isothiocyan-
ate, followed by phenol extraction and isopropanol pre-
cipitation. cDNA synthesis was performed in three parts
(A–C), by use of primers 2R, 4R, and 6R (see table 1).
Reactions were performed by use of 1–5 mg RNA and
Moloney murine-leukemia-virus reverse transcriptase in
a total volume of 20 ml. After incubation for 1 h, the
mixture was diluted to 40 ml, and 5 ml was used in PCR.
Each of the cDNA samples was amplified in two parts,
by the primers shown in table 1, so that the whole open
reading frame (ORF) was amplified as six fragments.
PCR mixtures contained 5 ml appropriate cDNA, 20
pmol primers, and 0.125 mM each dNTP, in a total
volume of 50 ml. PCR conditions were 35 cycles at 94C
for 1 min, annealing (at temperatures indicated in table
1) for 1.5 min, and elongation at 72C for 3 min. The
products were reamplified by means of the same 3′ pri-
mer and a nested biotinylated 5′ primer, under conditions
identical to those described above. PCR products were
captured on streptavidin-coated Dynabeads and were
sequenced by means of the dideoxy termination proce-
dure with T7 DNA polymerase and 35S-dATP, as de-
scribed elsewhere (Steingrimsdottir et al. 1993).
In compound-heterozygote patients, in whom the mu-
tations in the two alleles were different, the sequencing
gel had both normal and mutant bands at the site of the
mutation. In many of these cases, we confirmed the mu-
tation by cloning the PCR products into a “T vector”
and sequencing several clones.
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Table 2
Mutations in CS-B Patients
Cell Line
Inactivating
Mutation(s)a Amino Acid Change Location
CS2TAN G1630A Trp517stop Exon 7
CS1TAN C2282T Arg735stop Exon 11
CS8BR C2639T Gln854stop Exon 13
25627 C2282T Arg735stop Exon 11
C1436T Arg453stop Exon 5
CS4BR C629T Gln184stop Exon 4
C2087T Arg670Trp Exon 10
CS1BO G 1597 and C2918T Frameshift 506r542stop and
Arg947stop
Exon 6 and 16
G3363C Pro1095Arg Exon 18
CS1BE C2087T Arg670Trp Exon 10
A 3615 Frameshift 1179r1200stop Exon 18
CS10BR 26nt 3686 Frameshift 1203r1235stop Exon 18
CS1ABR G 2223 Frameshift 715r738stop Exon 10
CS10LO T 1359 Frameshift 427r435stop Exon 5
CS2BE T 3614 Frameshift 1179r1200stop Exon 18
Deletion of exon 10 Deletion of 665723 Exon 10
CS2BI C2087T Arg670Trp Exon 10
C3204T Pro1042Leu Exon 18
CS3TAN T2630A Trp851Arg Exon 13
CS7TAN A3716G Arg1213Gly Exon 18
CS1IAF T2949G Val957Gly Exon 16
CS1MA Deletion of exon 10 Del 665–723 Exon 10
a Missense mutations shown to be inactivating by failure to restore UV resistance to UV61 cells.
Functional Complementation
Mutations were introduced into the CSB gene by
means of two different procedures. PCR products con-
taining the mutation of interest were cloned into a T
vector and were sequenced to check for the absence of
any PCR-induced spurious mutations. An appropriate
restriction fragment containing themutationwas excised
and used to replace the corresponding wild-type frag-
ment in the intact CSB gene in BlueScript. Alternatively,
the mutation was introduced directly into the gene by
site-directed mutagenesis using the procedure of Kunkel
et al. (1987). The entire ORF was checked for the ab-
sence of spurious mutations. The CSB gene was then
transferred as a BamHI fragment into the mammalian
expression vectors pCDNA3 or pCIneo (Invitrogen). For
transfection experiments, 5 # 105 UV61 cells were
plated on 9-cm dishes. Two days later, 40 ml polybrene
was added to the plates, followed by 5 mg DNA. After
6 h, the cells were treated with 20% dimethyl sulfoxide
in serum-free medium for 4 min. Two days later, the cells
were trypsinized, split into three aliquots, and replated
in the presence of 1 mg G418/ml. The cells on one dish
were grown and frozen as a mass population, and the
second dish was subjected to UV-irradiation selection
with three doses of 4 Jm2 with 2-day intervals between;
individual colonies were isolated from the third
plate and were grown for UV-irradiation–survival
experiments.
Results
The 16 patients whom we have analyzed all failed to
restore RNA synthesis to normal levels after UV irra-
diation, a phenotype that we regard as diagnostic for
CS (Lehmann et al. 1993). Cell-fusion studies have as-
signed these patients to the CS-B group (Lehmann 1982;
Stefanini et al. 1996). For molecular analysis, total cel-
lular RNA was reverse transcribed by use of three CSB-
specific primers. Each of the three cDNA samples was
then amplified in two parts by PCR, so that the whole
CSB cDNA was amplified in a total of six overlapping
fragments of ∼1 kb each, which were then sequenced
directly. Results of our analyses are summarized in table
2 and figure 1.
Nonsense Mutations
Four cell strains contained nonsense mutations in both
alleles, which resulted in truncation of 140% of the pro-
tein. Two Turkish patients, CS2TAN and CS1TAN, and
one British patient of Asian origin, CS8BR, all the off-
spring of consanguineous marriages, were homozygous
for G1630A, C2282T, and C2639T, respectively, which
convert Trp517, Arg735, and Gln854, respectively, to
stop codons. In 1978 we reported on a sun-sensitive
patient, designated “11961” (Arlett et al. 1978), who
was subsequently diagnosed as having CS and who was
assigned to group B (Lehmann 1982). We have deter-
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Figure 1 Inactivating amino acid changes caused by mutations in the CSB gene. The CSB protein is shown with the seven domains
conserved in DNA helicases (hatched boxes) and with the putative nuclear-localization signals (gray-shaded boxes). Amino acid changes resulting
from mutations are shown boxed, with the change indicated by white letters on a black background, and the cell-line designations are shown
below them. Subscripts “1” and “2” denote the different alleles. Mutations shown below the depicted protein result in protein truncations,
whereas those above the depicted protein are all single-amino-acid changes.
Table 3
Frameshifts and Insertions
Cell Strain Status Mutation First Mutated Codon Sequence
Size of Truncated Protein
(amino acids)
CS10LO Homozygous T 1355–1359 427 ACTTTTTCC 434
CS1ABR Homozygous G 2218–2223 715 ATGGGGGGAT 737
CS2BE Heterozygous T 3610–3614 1179 AATTTTTAT 1,199
CS1BE Heterozygous A 3615 1179 TTTTTATAAGC 1,199
CS1BO Heterozygous G 1597 506 AAAAAGCTTTTTT 541
CS10BR Homozygous 26nta 3686 1203 ACCAA 26 nta AGCAA 1,234
a Insertion of GG GCT GGC TGC TTA AGG TCC ACC TTA.
mined the sites of the mutations in cells fromhis similarly
affected brother, coded as “25627.” The patient is a
compound heterozygote: one allele contains the
Arg735opal mutation found in CS1TAN, and the other
allele contains the mutation C1436T, resulting in
Arg453opal. CS4BR, derived from a patient in the
United Kingdom, is a compound heterozygote with the
mutation C629T, resulting in Gln184opal in one allele.
CS1BO is a rare example of a black patient with CS.
She is a compound heterozygote with C2918T in one
allele, resulting in Arg947opal; this mutation is, how-
ever, not relevant for the pathological phenotype, since
it is 1,321 bases downstream of a frameshift mutation
in the same allele (see below).
Frameshifts and Insertions
Single-base frameshifts, all resulting in stop codons
7–35 amino acids downstream, were detected in six pa-
tients and are shown in table 3. Three of these were
single-base deletions or insertions in runs of five or six
identical bases, presumably the result of replication slip-
page, which could also account for the loss of an A
residue sandwiched between a run of 5 T’s and a single
T in CS1BE. In CS1BO there was a loss of a G residue
from the center of a 12 bp inverted repeat. In CS10BR
there was an insertion of 26 bases at position 3686, in
the middle of exon 18. The origin of this insertion is
not known. At the time of the writing of this report, this
sequence was not present in any of the publicly available
sequence databases.
Missense Mutations
A missense mutation, C2087T, causing an ArgrTrp
change at amino acid 670, has been found in one allele
of three unrelated patients, CS4BR and CS2BI from the
United Kingdom and CS1BE (GM1629) from the United
States. Arg670 is in helicase domain III and is part of a
stretch of 34 amino acids that are 97% identical or con-
served in CSB and the Saccharomyces cerevisiae ho-
mologue, Rad26 (van Gool et al. 1994). Two other mis-
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sense homozygous mutations were present in highly
conserved regions. Trp851Arg, found in CS3TAN from
Turkey, is close to helicase domain IV in a run of 37
amino acids that are 83% identical or conserved between
CSB and Rad26, and Val957Gly in CS1IAF from Israel
is in a run of 79 amino acids that are 97% conserved
between yeast and man. The other missense mutations
(Pro1042Leu, heterozygous in CS2BI; Pro1095Arg, het-
erozygous in CS1BO; and Arg1213Gly, homozygous in
CS7TAN) were in less-conserved regions of the protein,
but Pro1042Leu is located in the putative nuclear-lo-
calization sequence (Troelstra et al. 1992).
It is of interest that all six of the missense mutations
are in the C-terminal two-thirds of the protein. This
could indicate that the N-terminal third of the protein
is less important for the repair function of the CSB pro-
tein and that this domain is involved in some other func-
tion (for other possible roles of the CSB protein, see the
Discussion section). Preliminary results from site-di-
rected mutagenesis of the N-terminal part of the gene
are consistent with this possibility.
Splice Mutations
In two patients the CSB mRNA was abnormally
spliced. Exon 10 was absent from the cDNA of CS1MA,
suggesting that the mutation in both alleles affected the
splicing of this exon. This same exon was missing in one
allele of CS2BE. We have sequenced the regions around
the splice-donor site of intron 10 and the splice-acceptor
site of intron 9, in genomic DNA of CS1MA, but this
did not reveal the cause of the abnormal splicing. The
loss of exon 10 results in an in-frame deletion of 59
amino acids encompassing the whole of helicase domain
III.
Polymorphisms
In addition to the inactivating mutations, we have
detected the following changes in at least two pa-
tients: G214C (Leu45), C2830T (Gly917), G1275A
(Gly399Asp), A3368G (Met1097Val), and A4317G
(Gln1413Arg). We presume that Gly399Asp and
Met1097Val are silent. Residue 399 is Gly in the human
gene but is Asp in the mouse gene, and Met1097Val is
a conservative change. We show below that Gln1413Arg
is not inactivating. In patient CS7TAN, we found three
of the above-mentioned polymorphic changes, as well
as Arg1213Gly, which we show to be inactivating (see
below), and Lys255Thr, all mutations being homozy-
gous. Since Arg1213Gly is sufficient to account for the
repair-deficient phenotype, we presume that Lys255Thr
does not contribute to the phenotype.
Functional Studies
Ourmutation analyses have identified several different
types of mutation in the CSB gene. The nonsense, frame-
shift, and splice mutations have sufficiently severe effects
on the protein structure for us to be confident that they
are indeed the inactivating mutations. This contention
is supported by our recent results (to be presented else-
where) showing that deletion of only 25 amino acids
from the C-terminus of the protein completely abolishes
its repair function. In order to confirm that the missense
mutations that we identified were causative, we have
constructed intact CSB cDNAs containing these muta-
tions in Bluescript, either by subcloning fragments used
in our sequence analysis or by site-directed mutagenesis.
All cloned PCR products or mutated plasmids were se-
quenced in their entirety, to ensure that the DNA con-
tained only the desired mutations. The CSB cDNA was
then transferred, as a BamHI fragment, from Bluescript
into one of the mammalian expression vectors pCDNA3
or pCIneo. Normal and mutant plasmids were trans-
fected into the UV-sensitive CHO cell line UV61 (from
the same complementation group as the CS-B cells), and
selection for the neoR gene was applied by use of G418.
Clones were picked and expanded, and the remaining
clones in the dishes were trypsinized, respread, and sub-
jected to UV-irradiation selection with three doses, each
of 4 Jm2. This gave a crude measure of UV sensitivity
of the transfectants. Whereas a confluent layer of cells
resulted from the culture of UV61 cells that were trans-
fected with the wild-type CSB gene and then UV irra-
diated, very few cells survived after transfection with
either empty vector or the CSB gene containing the mu-
tations R670W, W851R, V957G, P1042L, or R1213G.
In contrast, when the cDNA contained mutation
Q1413R, which we presumed to be a silent polymor-
phism, the cells survived the UV-irradiation selection, as
did the wild-type transfectants.
The clones that were picked and expanded without
UV irradiation were examined by PCR, to ensure that
the transfected human CSB cDNA was intact. For each
transfection, two clones in which PCR indicated that the
whole of the cDNA was present were examined quan-
titatively for the effects that UV irradiation had on cell
survival. Results are shown in figure 2. These results
confirmed the findings seen with the batch cultures de-
scribed above. In early experiments, in which the
pCDNA3 expression vector was used, clones from cells
transfected with the wild-type gene were much more
resistant than were untransfected UV61 cells, although
the survival did not reach that of the wild-type parental
cell line AA8. In later experiments, with the pCIneo vec-
tor, the wild-type CSB gene restored the survival of
UV61 cells up to the level of the parental AA8 line.
Irrespective of which vector was used, the survival of
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Figure 2 UV-irradiation survival of UV61 cells transfected with
the CSB gene containing different mutations. Transfectants are from
CSB constructs made in pCDNA3 (a) or in pCIneo (b). “AA8” denotes
the normal parental hamster cell line from which UV61 was derived,
and all other cell lines are UV61 cells transfected with CSB constructs
containing the indicated mutations.
UV61 cells transfected with DNA containing the mu-
tations that we had identified as inactivating was indis-
tinguishable from that of cells transfected with the empty
vector. In contrast, the survival of transfectants with the
Q1413R DNA approached that of the normal
transfectant.
Discussion
We have identified the inactivating mutations in the
CSB gene in 16 affected patients. The results are sum-
marized in figure 1 and tables 2 and 4. A variety of
different types and positions of mutations result in the
CS phenotype. Of the 18 identified inactivating muta-
tions, four were CGrTA transitions at CpG sites, re-
sulting from deamination of 5-methylcytosine, a pro-
portion similar to that found in other human genetic
disorders; and a further five were transitions at other
sites, two were transversions, six were frameshifts, and
one was an aberrant splicing.
Twelve of the 18 mutations resulted in severely trun-
cated products, because of either stop codons, frame-
shifts, or splice abnormalities. In nine patients (table 4,
top), both alleles were affected in this way, and it is
highly unlikely that the CSB protein in these individuals
would have any functional ability. This was also found
in the single patient analyzed by Troelstra et al. (1992).
This demonstrates that CSB is not an essential gene, as
also has been found for the yeast RAD26 homologue
(van Gool et al. 1994) . Further evidence to support this
comes from the generation of a CSB knockout mouse,
which showed near-normal development (van der Horst
et al. 1997). Of the six missense mutations, three were
located in regions that were highly conserved not only
in the mouse CSB protein but also in the homologous
yeast Rad26 protein. These mutations lie either within
or very close to the helicase domains of the protein and
are likely to abolish any function associated with these
domains. Of the three other mutated sites, Arg1213 is
conserved in the human and mouse proteins. Pro1042,
which is mutated to leucine in one allele of CS2BI, is
not present in the mouse protein (G. T. J. van der Horst
and J. H. J. Hoeijmakers, personal communication), but
it is located in a putative nuclear-localization signal, and
we have shown that this alteration, like the other amino
acid changes indicated in figure 1, fails to restore UV-
irradiation resistance to UV61 cells.
The CS patients studied come from a wide range of
racial backgrounds, including Caucasian, Turkish, Indo-
Pakistani, Israeli Jewish, and Black patients. The clinical
features of CS are fairly heterogeneous, as can be seen
in table 4, in our earlier clinical survey (Lehmann et al.
1993), and in reviews in the literature (Nance and Berry
1992). We previously had found that, in those patients
in whom RNA synthesis failed to recover after UV ir-
radiation (a feature that we use as a diagnostic marker
for CS), the magnitude of this defect was broadly similar,
irrespective of the clinical features (Lehmann et al.
1993). Similar observations have been made in Japanese
patients, by Sugita et al. (1991). Lowry (1982 [also see
Nance and Berry 1992]) has suggested that CS can be
divided clinically into type I, with classical CS symptoms
that become manifest within the first few years of life,
and type II, with more-severe symptoms already mani-
fest prenatally. Cellular defects in the response to UV
irradiation appear to be similar for type I patients and
type II patients (Sugita et al. 1991). We do not have full
clinical histories of all the patients in our study, but at
least four of them—CS1MA, CS1ABR, CS8BR, and
CS1BO—had the more-severe, type II features. Three of
these are homozygous for mutations resulting in severely
truncated proteins, whereas CS1BO is a compound het-
erozygote and has the Pro1095Arg change in one allele.
However, six other patients also produced truncated
products from both alleles but had classical, type I fea-
tures. It thus seems unlikely that the assignment into one
of the two clinical types can be based on the position
or type of mutation; the clinical disparity is more likely
Table 4
CS Mutations and Symptoms
Patienta Amino Acid Changeb Racial Group
Age at Biopsy
(years)
Age at Onset
(years)
Pigmentary
Retinopathy Symptoms Gait Defectc Cataracts Caries Referenced
Truncated
protein in
both al-
leles:
CS10LO 1 nt 427 Black 4 .5 No Yes No ?
CS2TAN Trp517stop Turkish 9 1.5 Yes Yes No No Lehmann et al. (1993); 88
CS1MAe Deleton of 665–723 Caucasian 4 (died) 0 ? Yes Yes Yes Lehmann et al. (1993); 34
CS1ABRe 1 nt 715 Caucasian 6 0 Yes Stefanini et al. (1996)
CS1TAN Arg735stop Turkish 8 1.5 Yes Yes No Yes Lehmann et al. (1993); 77
25627 Arg735stop Caucasian 5 Yes Yes
Arg453stop
CS8BRe Gln854stop Indo-Pakistani .5 0
CS2BE 1 nt 1178 Caucasian 21 1 Yes Yes Brumback et al. (1978)
CS10BR
Deletion of 665–723
26 nt 1203 Caucasian 5 .2 No Yes Yes No
Missense
mutation
in at
least one
allele:
CS4BR Arg670Trp Caucasian 24 3 Yes Yes Yes Yes Lehmann et al. (1993); 39
Gln184stop
CS2BI Arg670Trp Caucasian 16 .7 Yes Yes Lehmann et al. (1993); 9
Pro1042Leu
CS1BE Arg670Trp Caucasian 11 1.5 Yes Yes No Brumback et al. (1978)
1 nt 1179
CS3TAN Trp851Arg Turkish 1.7 .3 No Yes No No Lehmann et al. (1993); 98
CS1IAF Val957Gly Israeli Jewish 7 2 Yes Yes Lehmann et al. (1993); 67
CS1BOe Pro1095Arg Black .75 0 Yes NA Yes Yes Stefanini et al. (1996)
1 nt 506
CS7TAN Arg1213Gly Turkish 18 2 Yes Yes No Yes
a Listed in order of amino acid position of truncation or frameshift.
b The mutation responsible for the pathological phenotype is underlined; for compound heterozygotes, the less severe mutation is underlined. This is assumed to be the
more C-terminal of two truncating mutations—or a missense mutation, if one allele is a truncation and the other is a missense mutation.
c NA  not applicable.
d Numbers refer to the designations of the patients in Lehmann et al. (1993).
e Type II patient with symptoms at birth.
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to result from other differences in genetic background
or in the intrauterine environment.
CS-B (and CS-A) cells are sensitive to the lethal effects
of UV irradiation and of a variety of chemical carcin-
ogens (Wade and Chu 1979). This is associated, in all
cases, with a failure of RNA synthesis to recover after
DNA damage (Mayne and Lehmann 1982). Until re-
cently this had been attributed to a deficiency in the
ability of CS to perform TCR—that is, the rapid removal
of damage from the transcribed strand of active genes
(van Hoffen et al. 1993). These observations, in turn,
have led to the suggestion that the function of the CS
gene products is to recruit theNERmachinery to actively
transcribed regions of DNA, a role analogous to that of
the transcription-repair coupling factor Mfd protein in
Escherichia coli (Selby and Sancar 1993). Although this
model has been widely accepted, it has recently been
questioned by some of its original proponents, who
found that, after damage to CS cells by the carcinogen
N-acetoxy-acetylaminofluorene, TCR occurs at normal
levels, although RNA synthesis fails to recover (vanOos-
terwijk et al. 1996). Those authors proposed that, after
UV irradiation, the dual-function transcription/repair
factor TFIIH is converted into a form utilized in NER
and that the function of the CS proteins is subsequently
to revert TFIIH from repair mode to transcriptionmode,
so that transcription can recommence. It has been pro-
posed that, in CS patients, TFIIH is locked in the repair
mode and transcription fails to recover (van Oosterwijk
et al. 1996). In an alternative model, the features of CS
have been suggested to result from defects in base ex-
cision repair of oxidative base damage (Cooper et al.
1997).
Except for sun sensitivity, the clinical features of CS
cannot be obviously attributed to defects in DNA repair.
This is in contrast to xeroderma pigmentosum, in which
most of the symptoms are readily explicable in terms of
a repair deficiency. It has therefore been suggested that
the CSB protein has a second function, possibly an in-
volvement with transcription, as has been found to be
the case with TFIIH (Bootsma and Hoeijmakers 1993;
Friedberg 1996). Although this is an attractive hypoth-
esis, CSB is not an essential gene, and therefore the CSB
protein cannot be an integral part of the transcriptional
machinery. Evidence in support of a role for the CS pro-
teins in general transcription comes both from data sug-
gesting that transcription rates are reduced in CS cells
(Balajee et al. 1997) and from data showing that
10%–15% of RNA polymerase II is strongly associated
with CSB protein in cell extracts (van Gool et al. 1997a).
This has led to the suggestion that the role of CSB might
be to release stalled transcription, by direct action on
the RNA polymerase II (van Gool et al. 1997b). An
alternative possibility is that CS genes are involved in
tissue-specific transcription. A gene that has been des-
ignated “ATR-X ” is another member of the SWI/SNF
superfamily. It is an X-linked gene that, when mutated,
specifically down-regulates expression of several genes,
including the a-globin gene on chromosome 16 (Gib-
bons et al. 1995; Picketts et al. 1996). One can envisage
that CSB might act in a similar manner on the expression
of a set of tissue-specific genes involved in aspects of
development that are abnormal in CS patients.
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